enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Hims & Hers’ surprise 85% Wegovy discount is latest ... - AOL

   www.aol.com/finance/hims-hers-surprise-85-wegovy...

   The compounded weight loss drug starts at $199 per month. ... $199 price tag for the company’s new product is still steep for some customers, he emphasized that Hims & Hers new GLP-1 weight loss ...

3. Hims & Hers offers compounded Wegovy for $99 a month to ... - AOL

   www.aol.com/news/hims-hers-offers-compounded...

   U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular weight-loss drug Wegovy to patients in certain professions for $99 a month.

4. Does Compounded Semaglutide Work for Weight Loss? - AOL

   www.aol.com/does-compounded-semaglutide-weight...

   Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. ... Hims & Hers offers compounded semaglutide starting at just $199 per month ...

5. Hims & Hers Health - Wikipedia

   en.wikipedia.org/wiki/Hims_&_Hers_Health

   [7] [15] In 2020, Hims launched mental health services, including anonymous group therapy. [5] In 2024, Hims announced it would add compounded GLP-1 injections to its product portfolio, giving customers a way to access weight loss treatment. Hims claims to be able to provide them cheaper and with greater availability.

6. Hims & Hers Selling GLP-1 Weight Loss Drugs Like Wegovy ... - AOL

   www.aol.com/lifestyle/hims-hers-selling-glp-1...

   Telehealth company Hims & Hers announced they will begin selling off-brand GLP-1 drugs similar to Ozempic and Wegovy at a significantly lower price. Here's how.

7. The FDA is about to make weight-loss drugs a lot harder to get

   www.aol.com/lot-harder-buy-knock-off-090602005.html

   Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're about to lose access. ... the stock price of Hims & Hers fell amid concerns ...